source
- Abivax's new ulcerative colitis data eases safety worries, sending shares up 25%Abivax released additional data on its experimental ulcerative colitis drug obefazimod. Earlier trial results had shown strong efficacy but raised safety concerns after several cancer cases were r…
- Anthropic launches Claude Science AI platform tailored for pharmaceutical researchAnthropic announced the availability of Claude Science, an AI application built on its large language model and aimed at scientific laboratories and pharmaceutical research. The tool is intended t…